Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA9 | Q16790 | 4/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.38 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.37 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13304049 | 1.00 | CA12 (0.40) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL15945161 | 0.93 | GPR84 (0.36) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL15945116 | 0.93 | GPR84 (0.36) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL14099671 | 0.93 | MCL1 (0.40) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL12770682 | 0.93 | MCL1 (0.40) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL12014673 | 0.91 | MCL1 (0.40) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL15945119 | 0.91 | ABCG2 (0.37) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL15945153 | 0.91 | ABCG2 (0.37) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL15945254 | 0.91 | CA12 (0.39) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL15945123 | 0.91 | CA12 (0.39) | CA12CA1CA2CA9MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8741449-B2 | Anthracene derivative, light-emitting material, material for light-emitting element, composition for coating, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-06-03 | — | — | US | disclosed |
| US-8741449-B2 | Anthracene derivative, light-emitting material, material for light-emitting element, composition for coating, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-06-03 | — | — | US | disclosed |
| EP-2112212-B1 | Anthracene derivative, light-emitting material, material for light-emitting element, composition for coating light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LAB (JP) | 2013-05-29 | — | — | EP | disclosed |
| US-20120241728-A1 | Anthracene Derivative, Light-Emitting Material, Material for Light-Emitting Element, Composition for Coating, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-09-27 | — | — | US | disclosed |
| US-20120241728-A1 | Anthracene Derivative, Light-Emitting Material, Material for Light-Emitting Element, Composition for Coating, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-09-27 | — | — | US | disclosed |
| US-8202632-B2 | Anthracene derivative, light-emitting material, material for light-emitting element, composition for coating, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-06-19 | — | — | US | disclosed |
| US-8202632-B2 | Anthracene derivative, light-emitting material, material for light-emitting element, composition for coating, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-06-19 | — | — | US | disclosed |
| US-20090267497-A1 | Anthracene Derivative, Light-Emitting Material, Material for Light-Emitting Element, Composition for Coating, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-10-29 | — | — | US | disclosed |
| US-20090267497-A1 | Anthracene Derivative, Light-Emitting Material, Material for Light-Emitting Element, Composition for Coating, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-10-29 | — | — | US | disclosed |
| EP-2112212-A2 | Anthracene derivative, light-emitting material, material for light-emitting element, composition for coating light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090267497-A1 | Anthracene Derivative, Light-Emitting Material, Material for Light-Emitting Element, Composition for Coating, Light-Emitting Element, Light-Emitting Device, and Electronic Device | CRY1, CCNE2, CRY2 | CA12 1213/4885CA1 1255/4885CA2 3451/4885 |
| US-20120241728-A1 | Anthracene Derivative, Light-Emitting Material, Material for Light-Emitting Element, Composition for Coating, Light-Emitting Element, Light-Emitting Device, and Electronic Device | CRY1, CCNE2, CRY2 | CA12 1213/4885CA1 1255/4885CA2 3451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.